02/08/2024 | Press release | Distributed by Public on 02/07/2024 20:03
This material is intended to notify the press release issued on February 7 (local time) by Bristol Myers Squibb, our license partner for Opdivo.
Please click https://www.bms.com/media/press-releases.html for the original press release.